FATE vs XRAY · rev $3.4M vs rev $1.78B
Fate Therapeutics Inc (FATE) versus Dentsply Sirona Inc (XRAY) — a side-by-side from cached financials, not a winner call.
Fate Therapeutics Inc (FATE) is a biotechnology company listed on US.
Dentsply Sirona Inc (XRAY) is a medical instruments & supplies company listed on NASDAQ.
Latest reported FATE revenue for 2026-06-30 was $3.4M. Net income was -$61.4M. FATE currently screens at market cap $331.0M.
Latest reported XRAY revenue for 2026-06-30 was $1.78B. Net income was $27.0M. XRAY currently screens at market cap $2.01B.
FATE currently screens at market cap $331.0M. XRAY currently screens at market cap $2.01B.
Not investment advice. Open the FATE and XRAY stock pages for the full models.
Not investment advice.